VANGUARD GROUP INC 13D and 13G filings for NeoGenomics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-13 5:09 pm Purchase | 2023-12-29 | 13G | NeoGenomics, Inc. NEO | VANGUARD GROUP INC | 14,169,665 11.120% | 494,920 (+3.62%) | Filing |
| 2023-02-09 11:27 am Purchase | 2022-12-30 | 13G | NeoGenomics, Inc. NEO | VANGUARD GROUP INC | 13,674,745 10.830% | 817,776 (+6.36%) | Filing |
| 2022-02-10 08:27 am Purchase | 2021-12-31 | 13G | NeoGenomics, Inc. NEO | VANGUARD GROUP INC | 12,856,969 10.440% | 1,689,391 (+15.13%) | Filing |
| 2021-02-10 11:28 am Purchase | 2020-12-31 | 13G | NeoGenomics, Inc. NEO | VANGUARD GROUP INC | 11,167,578 10.060% | 654,575 (+6.23%) | Filing |
| 2020-02-11 7:29 pm Purchase | 2019-12-31 | 13G | NeoGenomics, Inc. NEO | VANGUARD GROUP INC | 10,513,003 10.060% | 81,178 (+0.78%) | Filing |